Description
The DAC modification is designed to dramatically extend the compound’s circulating half-life relative to native GHRH by anchoring it to serum albumin, giving researchers a tool for studying sustained versus pulsatile GHRH receptor activation. It is frequently used in comparative pharmacokinetic research alongside non-DAC GHRH analogs and growth hormone secretagogues.
Research Applications
- Albumin-binding (DAC) pharmacokinetic research
- Sustained vs. pulsatile GHRH receptor activation studies
- Comparative GH-axis peptide research
- Half-life extension technology characterization
- Pituitary signaling pathway modeling
- Batch Number
- CAS Number
- Molecular Formula
- Molecular Weight
- Purity %
- Appearance
- Storage Instructions
- Solubility
- Research Applications
- Shipping Information
Disclaimer For laboratory research use only. Not for human consumption, clinical use, veterinary use, diagnosis, or therapeutic application.





Reviews
There are no reviews yet.